Bausch + Lomb Corporation operates as an eye health company worldwide. It operates through three segments: Vision Care/Consumer Health Care, Ophthalmic Pharmaceuticals, and Surgical. The Vision Care/Consumer Health Care segment provides contact lens that covers the spectrum of wearing modalities, including daily disposable and frequently replaced contact lenses; and contact lens care products, over-the-counter eye drops, eye vitamins, and mineral supplements that address various conditions comprising eye allergies, conjunctivitis, and dry eye. The Ophthalmic Pharmaceuticals segment offers proprietary and generic pharmaceutical products for post-operative treatments, as well as for the treatment of eye conditions, such as glaucoma, ocular hypertension, and retinal diseases; and contact lenses for therapeutic use. The Surgical segment provides tools and technologies for the treatment of cataracts, and vitreous and retinal eye conditions; and intraocular lenses and delivery systems, phacoemulsification equipment, and other surgical instruments and devices. The company was founded in 1853 and is headquartered in Vaughan, Canada.

Mr. Brenton L.  Saunders J.D.

Chief Executive Officer & Chairman

Mr. Osama A. Eldessouky

Executive Vice President & Chief Financial Officer

Mr. Alan  Waterhouse CPFA, MBA

Executive Vice President and Chief Supply Chain & Operations Officer

Mr. Jonathon L. Kellerman

Chief Compliance Officer

Mr. A. Robert D. Bailey

Executive Vice President & Chief Legal Officer

Dr. Yehia  Hashad M.D.

Executive Vice President of Research & Development and Chief Medical officer

Mr. Frederick J. Munsch

Senior Vice President, Controller & Chief Accounting Officer

T.J.  Crawford

Chief Communications Officer

Dr. Manisha A. Narasimhan Ph.D.

Chief Corporate Development & Digital Officer

Mr. Andrew  Stewart

President of Global Pharmaceuticals & International Consumer

Bausch + Lomb Corporation

Bausch + Lomb Corporation 経営体制

経営情報